Direktorat Registrasi ObatValid

REPASS

BPOM Number: DTL2106320433A1
Approved: 21 November 2024
Expiry: 23 December 2026
Form: SUSPENSI; 200 MG

About This Registration

REPASS is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DTL2106320433A1. Its current registration status is Valid, with the licence valid until 23 December 2026. The product is registered to ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA. BPOM first approved this registration in December 2021. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS 1 BOTOL @ 60 ML
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA
KOTA SEMARANG
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA
KOTA SEMARANG
primary
View profile →

Ingredients (1)

IBUPROFEN

Market Intelligence

Owner Portfolio: ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA holds 157 BPOM registrations
Manufacturer Scale: ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA produces 157 registered products
Registration Age: Registered for 4 years, 9 months
Expiry Status: Expires in 87 days